SAN DIEGO, CA / ACCESSWIRE / November 30, 2016 / The Shareholders Foundation, Inc. announces that a lawsuit was filed in the U.S. District Court for the Southern District of Florida on behalf of certain purchasers of shares of Alere Inc (NYSE: ALR) over alleged Violations of Securities Laws by Alere.

Investors who purchased shares of Alere Inc (NYSE: ALR) have certain options and for certain investors there are short and strict deadlines running. Deadline: January 13, 2017. NYSE: ALR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Alere’s wholly-owned subsidiary, Arriva Medical, LLC (“Arriva”), was submitting claims to Medicare for deceased patients, that the foregoing conduct subjected Arriva to revocation of its Medicare enrollment, and that as a result, defendants’ statements about Alere’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On November 4, 2016, Alere Inc announced that the Centers for Medicare and Medicaid Services alleged that the Company’s subsidiary, Arriva Medical, submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva’s Medicare enrollment.

Those who purchased Alere Inc (NYSE: ALR) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.

Michael Daniels

+1 (858) 779-1554

mail@shareholdersfoundation.com

3111 Camino Del Rio North

Suite 423

San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 450008

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against TreeHouse Foods Inc. (“TreeHouse” or the “Company”) (NYSE: THS) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired TreeHouse securities between February 1, 2016 and November 2, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/ths.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) that TreeHouse’s private label business and acquisition strategy were underperforming; (2) that TreeHouse exaggerated its full-year 2016 guidance; and (3) consequently, TreeHouse’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/ths or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in TreeHouse­ you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 449260

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Pattern Energy Group, Inc. (NASDAQ: PEGI) between May 9, 2016 and November 4, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Northern District of California. To get more information go to: http://www.zlk.com/pslra/pattern-energy or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Pattern’s operations were deficient with respect to various transaction, process level, and monitoring controls; (ii) as a result, Pattern lacked effective internal financial controls; and (iii) as a result of the foregoing, Pattern’s public statements were materially false and misleading at all relevant times.

On November 7, 2016, Pattern Energy announced its financial and operating results for the third quarter of 2016 and disclosed a material weakness in internal control over financial reporting. Pattern Energy stated that, as of September 30, 2016, its internal control “was not effective due to the aggregation of internal control deficiencies related to the implementation, design, maintenance, and operating effectiveness of various transaction, process level, and monitoring controls.”

If you suffered a loss in Pattern Energy, you have until January 10, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 450038

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against National Beverage Corp. (“National Beverage” or the “Company”) (NASDAQ: FIZZ) and certain of its officers, on behalf of shareholders who purchased National Beverage securities from July 16, 2015 through September 28, 2016, both dates inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that National Beverage lacked efficient internal controls over financial reporting, partially due to an undisclosed expenses through off book entities and undisclosed material related parties transactions. Consequently, defendants’ statements regarding National Beverage’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On September 28, 2016, Glaucus Research Group published a report revealing: (1) that the Fizz’s former CEO and Chairman confessed to “manipulating FIZZ’s earnings . . . [and] directing his son to create fake invoices”; (2) that National Beverage refused “to allow a potential acquirer to perform adequate due diligence on the Company,” which led to the failure of the transaction, (3) and that National Beverage’s officers “are compensated by a privately held company” that disallows shareholder visibility; (4) that former counsel for the Company “testified that he and former FIZZ general counsel ‘fudged facts’ on behalf of FIZZ in a previous litigation”; (5) and that gifts of stock were not disclosed in the Company’s SEC filings. Following this news, National Beverage stock dropped $3.81 per share, or 8.19%, to close at $42.67 on September 28, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/fizz or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in National Beverage you have until December 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 446655

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Centene Corp. (“Centene” or the “Company”) (NYSE: CNC) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Centene securities between April 26, 2016, and September 6, 2016,both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/cnc.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

On March 24, 2016, Centene announced its acquisition of a health care insurance provider, Health Net, Inc. Following the acquisition of Health Net, Centene guaranteed investors that there had been no negative developments in the Health Net medical reserves. On July 26, 2016, the Company said that, “We did increase reserves for medical claims primarily associated with disputed substance abuse treatment center costs. Additionally, we recorded premium deficiency reserves primarily associated with Arizona and the California individual PPO business.” Following this news, Centene stock dropped close to 9%, to close at just $68.87 on July 26, 2016.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements about the recent acquisition of Health Net and failed to disclose that material adverse facts about Centene’s business, operations and prospects, including the underperformance of Health Net legacy insurance programs and the need to increase reserves to offset losses caused by these programs. Specifically, the Complaint alleges that Defendants failed to inform investors (1) that some of Health Net’s insurance programs were failing; (2) that Health Net’s insurance plans were producing substantial losses; (3) that the Company had overstated Health Net’s financial predictions; and (4) consequently, Defendants’ statements about Centene’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/cnc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Centene you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 449274

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against TerraVia Holdings, Inc. (“TerraVia” or the “Company”) (NASDAQ: TVIA) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Arrowhead securities between August 8, 2016 and November 7, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/tvia.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) TerraVia’s products caused gastrointestinal problems, including nausea and vomiting; and (2) consequently, Defendants’ statements about TerraVia’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.

On November 7, 2016, Bloomberg broadcasted a news report, “Soylent Thinks It Found What Was Making People Sick: Algae.” The article described how Soylent, Rosa Foods, Inc.’s meal replacement drink, includes an algal flour ingredient provided by TerraVia. This ingredient has caused Soylent consumers to become sick and Rosa Foods said it will remove the ingredient by early 2017. Mark Brooks, TerraVia’s Senior Vice President denied that the Company’s algal flour was responsible for making consumers sick, however Bloomberg added that TerraVia had sent a letter in July to EN-R-G Foods, LLC, a separate customer, warning that TerraVia’s algal protein ingredient had been linked to a “modest number of reports” with similar complaints and ailments, like nausea and vomiting, connected with EN-R-G’s Honey Stinger energy bar. Following this news, TerraVia stock dropped $0.15 per share, or 8.11%, to close at $1.70 on November 7, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/tvia or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in TerraVia you have until January 17,
2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 449182

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Lannett Company Inc. (“Lannett” or the “Company”) (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/lci.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) that Lannett’s drug pricing relied on unsustainable pricing methodologies; (2) that Lannett lacked sufficient internal controls for its drug pricing methodologies; and (3) consequently, Lannett’s public statements were materially false and misleading at all relevant times.

On November 3, 2016, Bloomberg News reported that Lannett was being investigated by the Justice Department, along with other companies including Mylan NV, Teva Pharmaceutical Industries Ltd, Allergan Plc, Impax Laboratories Inc., Sun Pharmaceutical Industries Ltd., Mayne Pharma Group Ltd., Endo International Plc and Taro Pharmaceutical Industries Ltd. Bloomberg News said that the “antitrust investigation by the Justice Department, begun about two years ago, now spans more than a dozen companies and about two dozen drugs, according to people familiar with the matter. The grand jury probe is examining whether some executives agreed with one another to raise prices, and the first charges could emerge by the end of the year, they said.” Following this news, Lannett stock dropped in value.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/lci or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Lannett­ you have until January
17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 449267

RADNOR, PA / ACCESSWIRE / November 30, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a class action lawsuit has been filed against StoneMor Partners L.P. (NYSE: STON) (“StoneMor” or the “Company”) on behalf of purchasers of the Company’s securities between January 19, 2012 and October 27, 2016, inclusive (the “Class Period”).

StoneMor investors who purchased their securities during the Class Period may, no later than January 20, 2017, petition
the Court to be appointed as a lead plaintiff representative of the class.

Investors who wish to discuss this action or request additional information about the lawsuit are encouraged to contact Kessler Topaz Meltzer & Check attorneys D. Seamus Kaskela or Adrienne O. Bell at (888) 299-7706 or online at: https://www.ktmc.com/new-cases/stonemor-partners-lp#join.

StoneMor is the second largest owner and operator of cemeteries and funeral homes in the US. As a limited partnership, StoneMor makes quarterly distribution payments to its unitholders.

The complaint alleges that, throughout the Class Period, StoneMor and certain of its executive officers made false and/or misleading statements and/or failed to disclose: (1) that the Company’s reported non-GAAP financial metrics were materially misleading and concealed the truth about the Company’s actual financial condition; and (2) that the primary purpose of the Company’s regular debt and equity offerings was to pay distributions to unitholders rather than to pay down indebtedness under the Company’s revolving credit facility as publicly stated. The complaint further alleges that, as a result of the foregoing, StoneMor’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.

As further detailed in the complaint, on September 2, 2016, StoneMor disclosed that it intended to restate its consolidated financial statements “to correct certain accounting errors.” On October 27, 2016, StoneMor announced a quarterly cash distribution of $0.33 per common unit – a 50% reduction from the prior quarter’s cash distribution.

Following this news, shares of the Company’s common units fell $11.08 per share, or nearly 45%, to close on October 28, 2016 at $13.74 per common unit, on heavy trading volume.

StoneMor investors may, no later than January 20, 2017, petition the Court to be designated as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. For additional information, or to learn how to participate in this action, please visit https://www.ktmc.com/new-cases/stonemor-partners-lp#join.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers, and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299-7706
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 450032

SCOTTSDALE, AZ / ACCESSWIRE / November 30, 2016 / NOHO, Inc. (OTCPINK: DRNK), a Wyoming corporation (the Company) announced the following:

The Company has completed an asset purchase agreement to acquire 1Tapp from The Weaver Group, LLC, a mobile web application. The transaction was accomplished using a portion of the newly converted preferred stock already issued to the insider shareholders and there will be no dilution to the common shareholders.

1Tapp is the Company’s new mobile web app that optimizes user interaction by providing an ease-of-use interface for customers to engage with the cannabis retail sector. The app allows customers to access and receive up to date information such as,

– Product promotions
– Rewards programs
– Gift cards
– Daily specials
– Store events
– Direct customer inquiry
– Pricing and new products

1Tapp gives cannabis dispensaries the ability to market directly to both patients and customers through a cost-effective web-based app.

CEO David Mersky, Chief Executive Officer of NOHO, Inc. commented, “This marks an enormous breakthrough in the Marijuana industry as dispensaries will no longer have to rely on stale directory sites that effectively prevent individual branding and do not provide metrics and user data. Dispensaries will now be able to take ownership of their own sales funnel, design their own engagement campaigns and compile their own customer data.

“To facilitate our marketing plans for the 1TAPP app,” continued CEO David Mersky, “We are opening a new state of the art telephone sales operation in Phoenix, AZ, located in the prestigious Biltmore area in January, 2017.

Currently, through our subsidiary, Meda360 Licensing, Inc., we are nearing completion of our proof of concept in Arizona, where we have 120 host sights installed, featuring the Company’s digital signage and media technology. The point of sale model will serve as the base for the Company to offer 1Tapp and other services as part of a larger suite of products, all designed for the small business to enhance customer engagement.

Finally, it gives me great pleasure to report that this model will be rolled out nationwide. We look forward to announcing updates as developments occur.

The Company has authorized its counsel to effectuate a name change from NOHO, Inc. to IMBUTEK Corporation, seeking to trade under the new proposed symbol of IMTK, or if not available then IUTK or IBTK. This change is intended to more accurately reflect the nature of the Company’s core advertising technology business. Until that process is completed, the stock will continue to trade under its current symbol: DRNK.

Safe Harbor for Forward-looking Statements:

This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, they are based on managements current beliefs and assumptions as to future events. However, since the company’s operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.

CONTACT:

Investor/Media Contact:
Phillip Sugarman
Investor Relations Partners
818-280-6800

SOURCE: NOHO, Inc.

ReleaseID: 450000